# CURE holdings: all 65 positions

> CURE holdings as of Oct 22, 2026: swaps on IXV worth 239.4% of net assets, and the cash behind them. Every line, with its source and date.

Data as of Oct 22, 2026. Rebuilt every trading night.

CURE held swaps on IXV worth 239.4% of its net assets on Oct 22, 2026. With the 60.6% it holds directly, its exposure is 300.0%.

Source: Direxion (<https://www.direxion.com/product/daily-healthcare-bull-3x-etf>).

| # | Holding | Ticker | Weight |
| --- | --- | --- | --- |
| 1 | IXV swap asset leg | IXV | 93.30% |
| 2 | IXV swap asset leg | IXV | 62.36% |
| 3 | IXV swap asset leg | IXV | 44.24% |
| 4 | IXV swap asset leg | IXV | 39.51% |
| 5 | ELI Lilly & Co |  | 9.65% |
| 6 | Johnson & Johnson |  | 5.96% |
| 7 | Abbvie Inc |  | 4.65% |
| 8 | Unitedhealth Group Inc |  | 3.52% |
| 9 | Merck & Co. Inc. |  | 3.35% |
| 10 | Thermo Fisher Scientific Inc |  | 2.31% |
| 11 | Amgen Inc |  | 2.23% |
| 12 | Gilead Sciences Inc |  | 1.80% |
| 13 | Abbott Laboratories |  | 1.64% |
| 14 | Pfizer Inc |  | 1.60% |
| 15 | Intuitive Surgical Inc |  | 1.45% |
| 16 | Danaher Corp |  | 1.33% |
| 17 | Vertex Pharmaceuticals Inc |  | 1.25% |
| 18 | Bristol-Myers Squibb Co |  | 1.19% |
| 19 | CVS Health Corp |  | 1.12% |
| 20 | Medtronic PLC |  | 1.09% |
| 21 | McKesson Corp |  | 1.09% |
| 22 | Stryker Corp |  | 0.99% |
| 23 | Elevance Health Inc |  | 0.89% |
| 24 | The Cigna Group |  | 0.77% |
| 25 | Regeneron Pharmaceuticals |  | 0.74% |
| | Dreyfus Govt Cash Man Ins | | 19.78% |
| | Goldman Finl Sq Trsry Inst 506 | | 8.42% |
| | Goldman Sachs Fin Gov 465 Institut | | 8.01% |

The largest 25 of 65 positions are shown. All of them: https://etfiq.com/funds/cure/holdings/cure-holdings.csv (CSV) or https://etfiq.com/funds/cure/holdings/index.json (JSON).

Fund page: https://etfiq.com/funds/cure

Cite: ETFIQ, Holdings of CURE, data as of Oct 22, 2026. https://etfiq.com/funds/cure/holdings/